- Home
- OABI vs BRY Comparison
OABI vs BRY Comparison
Compare OABI & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- BRY
- Stock Information
- Founded
- OABI 2012
- BRY 1909
- Country
- OABI United States
- BRY United States
- Employees
- OABI 114
- BRY N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- OABI Health Care
- BRY Energy
- Exchange
- OABI Nasdaq
- BRY Nasdaq
- Market Cap
- OABI 228.9M
- BRY 249.1M
- IPO Year
- OABI N/A
- BRY N/A
- Fundamental
- Price
- OABI $1.57
- BRY $3.18
- Analyst Decision
- OABI Strong Buy
- BRY Buy
- Analyst Count
- OABI 3
- BRY 2
- Target Price
- OABI $6.67
- BRY $4.00
- AVG Volume (30 Days)
- OABI 385.0K
- BRY 769.3K
- Earning Date
- OABI 08-06-2025
- BRY 11-06-2025
- Dividend Yield
- OABI N/A
- BRY 3.78%
- EPS Growth
- OABI N/A
- BRY N/A
- EPS
- OABI N/A
- BRY 0.07
- Revenue
- OABI $23,027,000.00
- BRY $701,914,000.00
- Revenue This Year
- OABI N/A
- BRY N/A
- Revenue Next Year
- OABI $44.99
- BRY $1.15
- P/E Ratio
- OABI N/A
- BRY $48.73
- Revenue Growth
- OABI 6.05
- BRY N/A
- 52 Week Low
- OABI $1.22
- BRY $2.11
- 52 Week High
- OABI $4.87
- BRY $5.90
- Technical
- Relative Strength Index (RSI)
- OABI 38.28
- BRY 54.89
- Support Level
- OABI $1.51
- BRY $3.16
- Resistance Level
- OABI $1.73
- BRY $3.32
- Average True Range (ATR)
- OABI 0.12
- BRY 0.13
- MACD
- OABI -0.01
- BRY 0.01
- Stochastic Oscillator
- OABI 11.32
- BRY 67.74
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.